Cyclacel Pharmaceuticals, Inc. (CYCC) financial statements (2020 and earlier)

Company profile

Business Address 200 CONNELL DRIVE
BERKELEY HEIGHTS, NJ 07922
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12182417204358
Cash and cash equivalents12182417202431
Short-term investments     1826
Receivables 00 00 
Prepaid expense1101110
Disposal group, including discontinued operation    001
Deposits current assets 000000
Other current assets0000 01
Other undisclosed current assets11123(15)(24)
Total current assets:14202620252935
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment0000000
Assets of disposal group, including discontinued operation0
Total noncurrent assets:1000000
TOTAL ASSETS:15202620252936
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2445677
Accounts payable1322233
Accrued liabilities2233455
Disposal group, including discontinued operation    000
Other liabilities      0
Total current liabilities:2445677
Noncurrent Liabilities
Long-term debt and lease obligation1      
Operating lease, liability1
Liabilities, other than long-term debt  0000 
Other liabilities  0000 
Other undisclosed noncurrent liabilities 0     
Total noncurrent liabilities:100000 
Total liabilities:4545687
Stockholders' equity
Stockholders' equity attributable to parent12152214192228
Common stock0000000
Additional paid in capital370366365350343331318
Accumulated other comprehensive loss(1)(1)(1)(1)(1)(0)(0)
Accumulated deficit(358)(350)(343)(335)(323)(309)(289)
Total stockholders' equity:12152214192228
TOTAL LIABILITIES AND EQUITY:15202620252936

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 0 1221
Revenue, net 1221
Cost of revenue(0)  (0)  (6)
Gross profit:(0)0 122(4)
Operating expenses(10)(10)(9)(15)(18)(24)(14)
Operating loss:(10)(10)(9)(14)(16)(22)(18)
Nonoperating income (expense)1110(0)(0)6
Investment income, nonoperating0000000
Foreign currency transaction gain (loss), before tax0(0)(0)0(0)(0)0
Other nonoperating income0110006
Loss from continuing operations before income taxes:(9)(9)(8)(14)(16)(23)(12)
Income tax benefit1112232
Loss from continuing operations:(8)(7)(7)(12)(14)(19)(10)
Income (loss) from discontinued operations     0(0)
Net loss:(8)(7)(7)(12)(14)(19)(10)
Other undisclosed net income attributable to parent      0
Net loss attributable to parent:(8)(7)(7)(12)(14)(19)(10)
Preferred stock dividends and other adjustments(0)(0)(0)(0)   
Other undisclosed net loss available to common stockholders, basic    (0)(0)(9)
Net loss available to common stockholders, basic:(8)(7)(8)(12)(15)(20)(19)
Other undisclosed net loss available to common stockholders, diluted  (7)    
Net loss available to common stockholders, diluted:(8)(7)(15)(12)(15)(20)(19)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(8)(7)(7)(12)(14)(19)(10)
Comprehensive loss:(8)(7)(7)(12)(14)(19)(10)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)    
Comprehensive loss, net of tax, attributable to parent:(8)(7)(8)(12)(14)(19)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: